Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Am J Perinatol. 2016 Sep 20;34(5):458–464. doi: 10.1055/s-0036-1593349

Table 1.

Demographics

G-CSF No G-CSF

N=2142 (%) N=28,563 (%)
Gestational age, weeks
 <26 480 (22) 4544 (16)
 26–28 751 (35) 7942 (28)
 29–32 524 (24) 9448 (33)
 33–36 230 (11) 4230 (15)
 ≥37 155 (7) 2377 (8)
Birth weight, g
 <1000 1170 (55) 10,929 (38)
 1000–1499 463 (22) 8169 (29)
 1500–2499 326 (15) 6536 (23)
 2500–3499 137 (6) 2150 (8)
 ≥3500 45 (2) 751 (3)
Postnatal age, days
 ≤7 20,768 (73) 1538 (72)
 8–30 3584 (13) 358 (17)
 >30 4211 (15) 246 (11)
5-min Apgar score
 0–3 110 (5) 1255 (5)
 4–6 448 (21) 4304 (15)
 7–10 1533 (73) 22312 (80)
Race
 White 1037 (50) 13,360 (48)
 Black 526 (25) 7564 (27)
 Hispanic 401 (19) 5305 (19)
 Other 108 (5) 1410 (5)
Small for gestational age 696 (33) 6099 (21)
Male 1311 (61) 16948 (59)
Cesarean section 1548 (73) 20436 (72)
Maternal hypertension* 356 (17) 4296 (15)
Inotropic support 640 (30) 3562 (12)
Ventilator support 1443 (47) 12,745 (45)
Concurrent bacteremia 134 (6) 1007 (4)
*

Maternal hypertension includes preeclampsia, eclampsia and HELLP (hemolysis, elevated liver enzymes, low platelet) syndrome.

On the first day of neutropenia (untreated group) or first day of G-CSF therapy (treated group).